Cibinqo Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

CIBINQO 50 mg film-coated tablets: Pink, oval tablet 10.50 mm long and 4.75 mm wide, debossed with "PFE" on one side and "ABR 50" on the other.
Each film-coated tablet contains 50 mg abrocitinib.
CIBINQO 100 mg film-coated tablets: Pink, round tablet 9.00 mm in diameter, debossed with "PFE" on one side and "ABR 100" on the other.
Each film-coated tablet contains 100 mg abrocitinib.
CIBINQO 200 mg film-coated tablets: Pink, oval tablet 18.42 mm long and 8.00 mm wide, debossed with "PFE" on one side and "ABR 200" on the other.
Each film-coated tablet contains 200 mg abrocitinib.
Excipient with known effect: Each CIBINQO 50 mg film-coated tablet contains 1.365 mg of lactose monohydrate.
Each CIBINQO 100 mg film-coated tablet contains 2.73 mg of lactose monohydrate.
Each CIBINQO 200 mg film-coated tablet contains 5.46 mg of lactose monohydrate.
Excipients/Inactive Ingredients: Tablet core: Microcrystalline cellulose, Dibasic calcium phosphate anhydrous, Sodium starch glycolate, Magnesium stearate.
Film-coat: Hypromellose (E464), Titanium dioxide (E171), Lactose monohydrate, Macrogol/PEG, Triacetin (E1518), Iron red oxide (E172).

abrocitinib

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma